These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 4277335)

  • 1. A method for the isolation and determination of 3-methoxytyramine in brain tissue.
    Kehr W
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 284(2):149-58. PubMed ID: 4277335
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of different substrates on the inhibition of rat brain and liver monoamine oxidase by arylalkylhydrazines.
    Popov N; Matthies H; Lietz W; Thiemann C; Jassmann E
    Biochem Pharmacol; 1970 Aug; 19(8):2413-8. PubMed ID: 5520601
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of five clinically used inhibitors of monoamine oxidase using the fluorescence microscopy method.
    Bartonícek V
    Med Pharmacol Exp Int J Exp Med; 1967; 16(2):142-6. PubMed ID: 5298397
    [No Abstract]   [Full Text] [Related]  

  • 4. On the selective inhibition by some monoamine oxidase inhibitors of deamination of biogenic monoamines in vivo.
    Gorkin VZ; Romanova LA
    Biochem Pharmacol; 1968 Jun; 17(6):855-60. PubMed ID: 5661349
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of monoamine oxidase inhibitors on some arylalkylamines in rate striatum.
    Philips SR; Boulton AA
    J Neurochem; 1979 Jul; 33(1):159-67. PubMed ID: 572413
    [No Abstract]   [Full Text] [Related]  

  • 6. A double column procedure for the simultaneous estimation of norepinephrine, normetanephrine, dopamine, 3-methoxytyramine and 5-hydroxytryptamine in brain tissue.
    Karasawa T; Furukawa K; Yoshida K; Shimizu M
    Jpn J Pharmacol; 1975 Dec; 25(6):727-36. PubMed ID: 1228255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of certain monoamine oxidase inhibitors on isoproterenol-induced cardiac necrosis in rats.
    Stanton HC; Schwartz A
    Proc West Pharmacol Soc; 1966; 9():6-8. PubMed ID: 4381147
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential effects of monoamine oxidase inhibitors.
    Maickel RP; Rompalo AM; Cox RH
    Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):727-30. PubMed ID: 4420181
    [No Abstract]   [Full Text] [Related]  

  • 9. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.
    Maître L
    J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple forms of monoamine oxidase. Comparison of in vitro and in vivo inhibition patterns.
    Collins GG; Youdim MB; Sandler M
    Biochem Pharmacol; 1972 Jul; 21(14):1995-8. PubMed ID: 4405452
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of perturbation of cerebral amine metabolism on operationally defined learning and memory processes of goldfish.
    Stahl SM; Narotzky RA; Boshes B; Zeller EA
    Biol Psychiatry; 1974 Dec; 9(3):295-323. PubMed ID: 4441577
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of pretreatment with monoamine oxidase inhibitors or (+)-amphetamine on leptazol convulsions in mice and rats.
    Turner TA; Spencer PS
    J Pharm Pharmacol; 1968 Dec; 20():Suppl:122S+. PubMed ID: 4388144
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective inhibition of monoamine oxidase in rat brain mitochondria.
    Fuller RW; Warren BJ; Molloy BB
    Biochem Pharmacol; 1970 Nov; 19(11):2934-6. PubMed ID: 5512701
    [No Abstract]   [Full Text] [Related]  

  • 14. Serotonin-containing neurons in brain: depression of firing by monoamine oxidase inhibitors.
    Aghajanian GK; Graham AW; Sheard MH
    Science; 1970 Sep; 169(3950):1100-2. PubMed ID: 5449322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HISTOCHEMICAL AND BIOCHEMICAL DETECTION OF MONOAMINE RELEASE FROM BRAIN NEURONS.
    CARLSSON A; DAHLSTROEM A; FUXE K; LINDQVIST M
    Life Sci (1962); 1965 Apr; 4():809-16. PubMed ID: 14343933
    [No Abstract]   [Full Text] [Related]  

  • 16. Epinephrine accumulation in rat brain after chronic administration of pargyline and LY 51641--comparison with other brain amines.
    Mefford IN; Roth KA; Jurik SM; Collman V; McIntire S; Tolbert L; Barchas JD
    Brain Res; 1985 Jul; 339(2):342-5. PubMed ID: 2411347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the action of monoamine oxidase inhibitors on the noradrenaline uptake system and their antidepressant efficacy.
    Hendley ED; Snyder SH
    Nature; 1968 Dec; 220(5174):1330-1. PubMed ID: 5701350
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of substrate in the inhibition of rat liver and brain monoamine oxidase.
    Fuller RW
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):32-7. PubMed ID: 4386711
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inhibition by monoamine oxidase inhibitors of substrate induction of liver tryptophan pyrrolase and increase in brain serotonin].
    Samsonova ML; Oksenkrug GF
    Vopr Med Khim; 1972; 18(2):198-202. PubMed ID: 4679586
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of acutely administered analgesic drugs on rat brain serotonin turnover.
    Goodlet I; Sugrue MF
    Eur J Pharmacol; 1974 Dec; 29(2):241-8. PubMed ID: 4442443
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.